Clinical Trials Sponsored by MeiraGTx UK II Ltd
Total 15 results
-
MeiraGTx UK II LtdCompletedLeber Congenital AmaurosisUnited Kingdom, United States
-
MeiraGTx UK II LtdCompletedHead and Neck Cancer | Radiation-Induced Parotid Gland Hypofunction | Xerostomia Due to RadiotherapyUnited States, Canada
-
MeiraGTx, LLCActive, not recruitingParkinson DiseaseUnited States
-
MeiraGTx UK II LtdCompletedNatural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65Leber Congenital AmaurosisUnited Kingdom, United States
-
MeiraGTx, LLCRecruitingGrade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid GlandsUnited States, Canada
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
MeiraGTx, LLCEnrolling by invitationParkinson DiseaseUnited States
-
MeiraGTx UK II LtdJanssen, LPActive, not recruitingRetinitis PigmentosaUnited States, United Kingdom, Canada
-
MeiraGTx UK II LtdJanssen Research & Development, LLCCompleted
-
MeiraGTx UK II LtdSyne Qua Non LimitedCompletedEye Diseases | Retinal Diseases | Eye Diseases, Hereditary | Leber Congenital Amaurosis (LCA)United States, United Kingdom
-
MeiraGTx, LLCNational Institute of Dental and Craniofacial Research (NIDCR)Active, not recruitingSquamous Cell Head and Neck Cancer | Radiation Induced Xerostomia | Salivary HypofunctionUnited States
-
MeiraGTx UK II LtdSyne Qua Non Limited; EMAS PharmaCompleted
-
MeiraGTx UK II LtdSyne Qua Non Limited; EMAS PharmaActive, not recruitingAchromatopsiaUnited Kingdom, United States
-
MeiraGTx UK II LtdSyne Qua Non Limited; Bionical EmasCompletedGene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)X-Linked Retinitis PigmentosaUnited Kingdom, United States